Please login to the form below

Not currently logged in
Email:
Password:

GW Pharma's cannabis-based medicine to be tested in dementia

GW Pharma sativex nabiximols MS

Trial will be funded by Alzheimer’s Research UK

Merck puts prostate cancer firmly in Keytruda’s sights

Merck and Co - US headquartersLynparza combination could open up huge new market

Bicycle Therapeutics to tackle AMR with government funding

Bicycle 1Biotech to discover new class of antibacterial agents

Gilead lead NASH drug flunks phase 3 test

GileadAnalysts suspect the setback could prompt Gilead to license other candidates

Grey Wolf secures £10m Series A to ‘illuminate’ tumour cells

The tech could offer a new treatment paradigm

UniQure edges closer to haemophilia B gene therapy OK

Gene therapy graphic - UniQureThe candidate could free patients from regulator injections of FIX products

Trial dents confidence in Sangamo’s gene-editing tech

SangamoCompany proposing switch to next-gen version

Galapagos expands presence in fibrosis, NASH with Evotec deal

GalapagosAs lead candidate filgotinib nears filing, firm looks to expand horizons

GSK gets serious about immunotherapy with Merck deal worth up to $4.2bn

Merck KGaAPartners to co-develop novel bifunctional fusion protein

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...

Infographics